Pitfalls of CD45 gating strategies in leukaemia immunophenotyping

Clinical and Laboratory Haematology

Volumn 25, Issue 1, 2003, Pages 67-

  Lock, R J ^a   Virgo, P F ^a   Evely, R S ^b  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD34 ANTIGEN; CD45 ANTIGEN; MONOCLONAL ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN DETECTION; DIAGNOSTIC TEST; HUMAN; IMMUNOPHENOTYPING; LETTER; LEUKEMIA; MINIMAL RESIDUAL DISEASE; PLASMA CELL LEUKEMIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; TECHNIQUE;

ANTIGENS, CD45; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA;

EID: 0037328078     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2003.00489.x     Document Type: Letter

References (4)

1. Bain B., Barnett D., Linch D., Matutes E. & Reilly J.T. (2002) Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. Clinical and Laboratory Haematology 24, 1-13.
2. Ratei R., Sperling C., Karawajew L., Schott G., Schrappe M., Harbott J., Riehm H. & Ludwig W.D. (1998) Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia. Annals Hematology 77, 107-114.
3. Campana D. & Coustan-Smith E. (1999) Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry 38, 139-152.
4. Joshua D., Petersen A., Brown R., Pope B., Snowdon L. & Gibson J. (1996) The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis. British Journal of Haematology 94, 76-81.